When.com Web Search

  1. Ads

    related to: sorafenib inhibitor over the counter

Search results

  1. Results From The WOW.Com Content Network
  2. Sorafenib - Wikipedia

    en.wikipedia.org/wiki/Sorafenib

    Sorafenib, sold under the brand name Nexavar, [3] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.

  3. FDA approves new pain medication as an alternative to opioids ...

    www.aol.com/news/fda-approves-pain-medication...

    For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

  4. List of antidepressants - Wikipedia

    en.wikipedia.org/wiki/List_of_antidepressants

    The following antidepressants are available both with a prescription and over-the-counter: Ademetionine [S-Adenosyl-L-methionine (SAMe)] (Heptral, Transmetil, Samyl) – cofactor in monoamine neurotransmitter biosynthesis; Hypericum perforatum [St. John's Wort (SJW)] (Jarsin, Kira, Movina) – TRPC6 activator, and various other actions

  5. Medicare announces weight-loss drugs, including Ozempic ... - AOL

    www.aol.com/medicare-announces-15-drugs-price...

    The drugs have faced public backlash over their high price, fueling demand for cheaper alternatives. The list, which includes 15 drugs, up from 10 last year, is the first step in a negotiation ...

  6. Donafenib - Wikipedia

    en.wikipedia.org/wiki/Donafenib

    Donafenib, sold under the brand name Zepsun, is a pharmaceutical drug for the treatment of cancer.. In China, donafenib is approved for the treatment of unresectable hepatocellular carcinoma in patients who have not previously received systemic treatment.

  7. Regorafenib - Wikipedia

    en.wikipedia.org/wiki/Regorafenib

    Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti- angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.

  1. Ads

    related to: sorafenib inhibitor over the counter